Brand · Tablet · Updated Nov 11, 2026
Savaysa 60 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for savaysa 60 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Savaysa 60 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $465.35
- 52-week low
- $438.97
- 52-week high
- $465.35
- A year ago
- $439.01
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Jul 1, 2026 | $14.63 | $15.51 | +6.0% | WAC Adjustment |
| May 20, 2026 | $14.63 | $14.63 | No change | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $14.66 | $14.63 | -0.2% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $14.68 | $14.66 | -0.1% | pharmacies' invoice prices changed (survey) |
| Feb 18, 2026 | $14.66 | $14.68 | +0.1% | pharmacies' invoice prices changed (survey) |
| Jan 21, 2026 | $14.67 | $14.66 | -0.1% | pharmacies' invoice prices changed (survey) |
| Dec 17, 2025 | $14.68 | $14.67 | No change | pharmacies' invoice prices changed (survey) |
| Nov 19, 2025 | $14.63 | $14.68 | +0.3% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for savaysa 60 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Every manufacturer and package code
1 company sell savaysa 60 mg tablet under 1 package code (NDC).
| Maker | Package codes | Per unit |
|---|---|---|
| Daiichi Sankyo Inc. | 65597-203-30 | $15.51 |
All 1 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other savaysa strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 30 mg tablet Brand | $15.48 | $464.44 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015
WARNING: (A) REDUCED EFFICACY IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH CREATININE CLEARANCE (CRCL) > 95 ML/MIN (B) PREMATURE DISCONTINUATION OF SAVAYSA INCREASES THE RISK OF ISCHEMIC EVENTS (C) SPINAL/EPIDURAL HEMATOMA
WARNING: (A) REDUCED EFFICACY IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH CREATININE CLEARANCE (CRCL) > 95 ML/MIN (B) PREMATURE DISCONTINUATION OF SAVAYSA INCREASES THE RISK OF ISCHEMIC EVENTS (C) SPINAL/EPIDURAL HEMATOMA
See full prescribing information for complete boxed warning.
(A) REDUCED EFFICACY IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH CRCL > 95 ML/MIN: SAVAYSA should not be used in patients with CrCL > 95 mL/min. In the ENGAGE AF-TIMI 48 study, nonvalvular atrial fibrillation patients with CrCL > 95 mL/min had an increased rate of ischemic stroke with SAVAYSA 60 mg once daily compared to patients treated with warfarin. In these patients another anticoagulant should be used (5.1).
(B) PREMATURE DISCONTINUATION OF SAVAYSA INCREASES THE RISK OF ISCHEMIC EVENTS: Premature discontinuation of any oral anticoagulant in the absence of adequate alternative anticoagulation increases the risk of ischemic events. If SAVAYSA is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant as described in the transition guidance (2.4, 5.2, 14).
(C) SPINAL/EPIDURAL HEMATOMA: Epidural or spinal hematomas may occur in patients treated with SAVAYSA who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures (5.4).
A. REDUCED EFFICACY IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH CRCL > 95 ML/MIN
SAVAYSA should not be used in patients with CrCL > 95 mL/min. In the ENGAGE AF-TIMI 48 study, nonvalvular atrial fibrillation patients with CrCL > 95 mL/min had an increased rate of ischemic stroke with SAVAYSA 60 mg once daily compared to patients treated with warfarin. In these patients another anticoagulant should be used [see Dosage and Administration (2.1), Warnings and Precautions (5.1), and Clinical Studies (14.1)].
B. PREMATURE DISCONTINUATION OF SAVAYSA INCREASES THE RISK OF ISCHEMIC EVENTS
Premature discontinuation of any oral anticoagulant in the absence of adequate alternative anticoagulation increases the risk of ischemic events. If SAVAYSA is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant as described in the transition guidance [see Dosage and Administration (2.4), Warnings and Precautions (5.2), and Clinical Studies (14.1)].
C. SPINAL/EPIDURAL HEMATOMA
Epidural or spinal hematomas may occur in patients treated with SAVAYSA who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
use of indwelling epidural catheters
concomitant use of other drugs that affect hemostasis, such as nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants
a history of traumatic or repeated epidural or spinal punctures
a history of spinal deformity or spinal surgery
optimal timing between the administration of SAVAYSA and neuraxial procedures is not known
[see Warnings and Precautions (5.4)].
Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary [see Warnings and Precautions (5.4)].
Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated [see Warnings and Precautions (5.4)].
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about savaysa 60 mg tablet
How much does savaysa 60 mg tablet cost without insurance?
Pharmacies pay about $465.35 for 30 tablets ($15.51 per tablet) as of November 11, 2026. A fair cash price is about $545.65: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $545.15 including shipping.
Is my price for savaysa 60 mg tablet fair?
Compare it with the fair cash price of $545.65 for 30 tablets. Up to about $682.06 is fair; above $1,091.30 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is savaysa 60 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it rose 6.0%. See the 52-week chart.
Who makes savaysa 60 mg tablet?
1 company: Daiichi Sankyo Inc.. See every package code.
Is savaysa in shortage?
No shortage is reported right now. We check every day.
Has savaysa been recalled?
No recalls are on record.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about savaysa 60 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.